Psychedelics
Awakn Loses Psychedeclics Chief, Gains New Treatment Clinics
The company also opened a new clinic in Norway.
The post Awakn Loses Psychedeclics Chief, Gains New Treatment Clinics appeared first on Green Market R…
Canada-based biotech firm Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) has lost its head of psychedelic medicine, but due to the loss, it gained full ownership in one of its clinics.
Dr. Ben Sessa resigned his position as head of psychedelic medicine at the company, effective April 13, Awakn disclosed in a press release. As part of the exit, Sessa is transferring his 49% ownership in Awakn Bristol Limited, with Awakn Clinics Bristol in England, to Awakn Life Sciences Inc., giving the company 100% ownership in the British psychedelics clinic.
In the same press release, Awakn announced that it had commenced treatments for alcohol use disorder with patients at a Manhattan facility run by Nushama Inc., one of Awakn’s licensing partners for its product line of Awakn Kare.
And on March 1, Awakn opened Awakn Clinics Trondheim in Norway for ketamine-assisted therapy. The opening marks the company’s fourth clinic globally and its second in Norway.
Awakn made headlines in February when the company was accused by OTC Markets group of running a stock promotion scheme, an allegation it denied.
The post Awakn Loses Psychedeclics Chief, Gains New Treatment Clinics appeared first on Green Market Report.
ketamine
psychedelic
therapy
markets
otc
psychedelics
biotech
life sciences
Psychedelic Search Trends in 2023
Take a look at this 2023 search volume chart. Do you think you can guess what’s happening? I was pretty shocked when I noticed this spike for December…
Here Are the Champions! Our Top Performing Stories in 2023
It has been quite a year – not just for the psychedelic industry, but also for humanity as a whole. Volatile might not be the most elegant word for it,…
Psilocybin shows promise for treating eating disorders, but more controlled research is needed
Recent psychedelic research shows promising results for mental illnesses and eating disorders, with surveys and reports indicating psilocybin-assisted…
